title: Cancer ovary, present and future of management.
abstract: Ovarian cancer is very important malignancy of woman as far as its incidence and mortality is concerned. Although majority presents at late stage but still there is a reasonable response to currently available chemotherapy drugs and their use in multimodality setting. Besides good response to chemotherapy drugs, majority have recurrence. So there is a need for new drugs, new trends and their combinations. All these issues will be discussed in this review article.
authors.affiliation: King Fahad Hospital, Al Madma Al Munawra, Kingdom of Saudi Arabia. tariq_parvez52@hotmail.com
authors.forename: Tariq
authors.initials: T
authors.lastname: Parvez
authors.forename: Tariq
authors.initials: T
authors.lastname: Pervez
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000592:standards / Q000639:trends; D005260:Female; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D010052:Ovariectomy / Q000379:methods; D010154:Pakistan; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome